Učitavanje...
Development of interstitial pneumonia during treatment with eribulin: a case report
BACKGROUND: Eribulin is typically used to treat patients with advanced breast cancer, and anti-cancer agents often cause the development of interstitial pneumonia in Japanese patients with advanced cancer. However, few case reports have addressed eribulin-induced interstitial pneumonia. Herein, we r...
Spremljeno u:
| Izdano u: | BMC Res Notes |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5674230/ https://ncbi.nlm.nih.gov/pubmed/29110735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-017-2882-4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|